Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behçet disease patients
- 1 January 2012
- journal article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 107 (01), 88-98
- https://doi.org/10.1160/th11-08-0556
Abstract
Schattauer GmbH - Verlag für Medizin und Naturwissenschaften ist ein renommierter Herausgeber von Fachbüchern, -zeitschriften und -software. Besuchen Sie unser Internetangebot mit Onlinezugang zu unseren ZeitschriftenartikelnThis publication has 50 references indexed in Scilit:
- Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosisBlood, 2010
- CD40 ligand shedding is regulated by interaction between matrix metalloproteinase‐2 and platelet integrin αIIbβ3Journal of Thrombosis and Haemostasis, 2010
- CD40L induces inflammation and adipogenesis in adipose cells – a potential link between metabolic and cardiovascular diseaseThrombosis and Haemostasis, 2010
- The multi-functionality of CD40L and its receptor CD40 in atherosclerosisThrombosis and Haemostasis, 2009
- Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligandGut, 2008
- Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder?Rheumatology, 2006
- Membrane-associated CD40L and sCD40L in atherothrombotic diseaseThrombosis and Haemostasis, 2003
- Inflammatory role of platelets in acute coronary syndromesHeart, 2001
- Behcet's disease: infectious aetiology, new autoantigens, and HLA-B51Annals Of The Rheumatic Diseases, 2001
- Behçet's DiseaseNew England Journal of Medicine, 1999